These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 27531286)

  • 21. Corneal endothelial damage after cataract surgery in eyes with pseudoexfoliation syndrome.
    Hayashi K; Manabe S; Yoshimura K; Kondo H
    J Cataract Refract Surg; 2013 Jun; 39(6):881-7. PubMed ID: 23582364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aqueous prostaglandin E(2) of cataract patients at trough ketorolac and bromfenac levels after 2 days dosing.
    Bucci FA; Waterbury LD
    Adv Ther; 2009 Jun; 26(6):645-50. PubMed ID: 19568702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparison of clinical effects of bromfenac sodium ophthalmic solution 0.1% versus glucocorticoids for post-LASEK usage].
    Chen S; Jiang Y; Yu C; Li Y
    Zhonghua Yan Ke Za Zhi; 2015 Jan; 51(1):45-50. PubMed ID: 25877710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nepafenac 0.1% plus dexamethasone 0.1% versus dexamethasone alone: effect on macular swelling after cataract surgery.
    Zaczek A; Artzen D; Laurell CG; Stenevi U; Montan P
    J Cataract Refract Surg; 2014 Sep; 40(9):1498-505. PubMed ID: 25135542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ophthalmic utility of topical bromfenac, a twice-daily nonsteroidal anti-inflammatory agent.
    Jones J; Francis P
    Expert Opin Pharmacother; 2009 Oct; 10(14):2379-85. PubMed ID: 19735215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topical 0.1% Bromfenac Sodium for Intraoperative Miosis Prevention and Prostaglandin E
    Chen H; Lin H; Chen W; Zhang B; Xiang W; Li J; Chen W
    J Ocul Pharmacol Ther; 2017 Apr; 33(3):193-201. PubMed ID: 28106471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retrospective review of the efficacy of topical bromfenac (0.09%) as an adjunctive therapy for patients with neovascular age-related macular degeneration.
    Zweifel SA; Engelbert M; Khan S; Freund KB
    Retina; 2009; 29(10):1527-31. PubMed ID: 19898185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bromfenac sodium 0.1%, fluorometholone 0.1% and dexamethasone 0.1% for control of ocular inflammation and prevention of cystoid macular edema after phacoemulsification.
    Wang QW; Yao K; Xu W; Chen PQ; Shentu XC; Xie X; Weng Y; Zhang L; Jin CF; Wu W; Zhu YN; Yu YH
    Ophthalmologica; 2013; 229(4):187-94. PubMed ID: 23429038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of sodium bromfenac eye drops in the treatment of postoperative inflammation in cataract surgery: A protocol for systematic review and meta-analysis.
    Wang C; Cao Y; Chen X; Cai M; Huang W
    Medicine (Baltimore); 2020 Dec; 99(49):e23131. PubMed ID: 33285687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparison of the effects of 0.1% bromfenac sodium eye drops and corticosteroids after small incision lenticule extraction].
    Jiang Y; Li Y; Jin YM; Zhang JY
    Zhonghua Yan Ke Za Zhi; 2017 Jan; 53(1):18-22. PubMed ID: 28162195
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of medicinal treatment on epithelial wound healing after phacoemulsification].
    Tomilova EV; Nemsitsveridze MN; Panova IE
    Vestn Oftalmol; 2017; 133(3):44-50. PubMed ID: 28745656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loteprednol etabonate 0.5% versus prednisolone acetate 1.0% for the treatment of inflammation after cataract surgery.
    Lane SS; Holland EJ
    J Cataract Refract Surg; 2013 Feb; 39(2):168-73. PubMed ID: 23232255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-inflammatory Medication of Cataract Surgery in Pseudoexfoliation Syndrome - NSAID Is Needed.
    Ilveskoski L; Taipale C; Tuuminen R
    Curr Eye Res; 2020 Jul; 45(7):814-819. PubMed ID: 31801388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nepafenac 0.1% versus fluorometholone 0.1% for preventing cystoid macular edema after cataract surgery.
    Miyake K; Ota I; Miyake G; Numaga J
    J Cataract Refract Surg; 2011 Sep; 37(9):1581-8. PubMed ID: 21855758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute corneal melt associated with topical bromfenac use.
    Prasher P
    Eye Contact Lens; 2012 Jul; 38(4):260-2. PubMed ID: 22169877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical bromfenac as an adjunctive treatment with intravitreal ranibizumab for exudative age-related macular degeneration.
    Gomi F; Sawa M; Tsujikawa M; Nishida K
    Retina; 2012 Oct; 32(9):1804-10. PubMed ID: 22718152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topical nonsteroidal anti-inflammatory drugs as adjuvant therapy in the prevention of macular edema after cataract surgery.
    Cardascia N; Palmisano C; Centoducati T; Alessio G
    Int Ophthalmol; 2017 Oct; 37(5):1127-1131. PubMed ID: 27766540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Macular edema after cataract surgery in eyes with and without pseudoexfoliation syndrome.
    Ilveskoski L; Taipale C; Holmström EJ; Tuuminen R
    Eur J Ophthalmol; 2019 Sep; 29(5):504-509. PubMed ID: 30205708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical bromfenac in VEGF-driven maculopathies: topical review and meta-analysis.
    Kulikov AN; Vasiliev AS; Kalinicheva YA; Maltsev DS
    BMC Ophthalmol; 2024 Aug; 24(1):369. PubMed ID: 39180057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The anti-inflammatory effect of 0.1% bromfenac and 0.1% betamethasone combination in post-cataract surgery patients with diabetes mellitus].
    Terada Y; Masuda A; Nejima R; Maruyama Y; Miyata K
    Nippon Ganka Gakkai Zasshi; 2014 Aug; 118(8):645-51. PubMed ID: 25223209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.